🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
AQS
$AQST
🔒 US EquitiesAquestive Therapeutics, Inc.
AVG HISTORICAL GAP
+0.94%
MAX GAP RECORD
+4.21%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $AQST
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$AQST
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 15, 2026 Earnings Release 2026-10-15 (AFTER CLOSE (17:00)) |
+0.95%
|
| Jul 13, 2026 Earnings Release 2026-07-13 (BEFORE OPEN) |
+0.00%
|
| Apr 23, 2026 Earnings Release 2026-04-23 (BEFORE OPEN) |
+0.00%
|
| Feb 12, 2026 Earnings Release 2026-02-12 (BEFORE OPEN) |
+1.79%
|
| Oct 16, 2025 Earnings Release 2025-10-16 (BEFORE OPEN) |
-2.24%
|
| Jul 15, 2025 Earnings Release 2025-07-15 (BEFORE OPEN) |
-2.80%
|
| Apr 23, 2025 Earnings Release 2025-04-23 (BEFORE OPEN) |
+4.21%
|
| Feb 13, 2025 Earnings Release 2025-02-13 (BEFORE OPEN) |
+3.74%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.6%
Bullish Gaps (3)
Bearish Gaps (2)
Neutral / Flat (1)
📖 Intelligence Summary
Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; EMYLIF, an oral film formulation of…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗